title: Balancing the cardiometabolic benefits and risks of statins.
authors.affiliation: Cardiometabolic Research Centre and Clinical Services, Royal Perth Hospital, University of Western Australia, Perth, WA 6001, Australia. gerald.watts@uwa.edu.au
authors.forename: Gerald F
authors.initials: GF
authors.lastname: Watts
authors.forename: Esther M
authors.initials: EM
authors.lastname: Ooi
mesh_terms: D002318:Cardiovascular Diseases / Q000517:prevention & control*; D003924:Diabetes Mellitus, Type 2 / Q000139:chemically induced*; D005260:Female; D005464:Fluorobenzenes / Q000627:therapeutic use*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D008297:Male; D011743:Pyrimidines / Q000627:therapeutic use*; D000068718:Rosuvastatin Calcium; D013449:Sulfonamides / Q000627:therapeutic use*
chemical_list: D005464:Fluorobenzenes; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011743:Pyrimidines; D013449:Sulfonamides; D000068718:Rosuvastatin Calcium